Belite Bio Inc ADR (BLTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
Operating Expenses | 6,881 | 0 | 2,540 | 2,506 | 0 |
Operating Income | -6,881 | N/A | -2,540 | -2,506 | N/A |
Other Income | -8 | 0 | 137 | 115 | 0 |
Pre-tax Income | -6,889 | 0 | -2,403 | -2,391 | 0 |
Income Tax | 6 | N/A | N/A | N/A | N/A |
Net Income Continuous | -6,895 | N/A | -2,403 | -2,391 | N/A |
Net Income | $-6,895 | $N/A | $-2,403 | $-2,391 | $N/A |
EPS Basic Total Ops | -0.33 | N/A | -0.10 | -0.12 | N/A |
EPS Basic Continuous Ops | -0.33 | N/A | -0.10 | -0.12 | N/A |
EPS Diluted Total Ops | -0.33 | N/A | -0.10 | -0.12 | N/A |
EPS Diluted Continuous Ops | -0.33 | N/A | -0.10 | -0.12 | N/A |
EPS Diluted Before Non-Recurring Items | -0.33 | N/A | N/A | N/A | N/A |
EBITDA(a) | $N/A | $N/A | $-2,540 | $-2,506 | $N/A |